Ann Tsukamoto of Stem Cells
joined us at World Orphan Drug Congress USA 2015 to present about '
Platform Technology for Rare CNS Diseases'
Download her presentation now to learn about:
-
HuCNS-SC: First Class in Biologic
-
HuCNS-SC Pre-Clinical Observations Reflected in Early Clinical Results
-
Gene Modified Human Neural Stem Cells
...and
much
more!
Get your copy here!
To find out more about
platform technology for rare CNS diseases
, attend
World Orphan Drug Congress USA 2016 April 20-22
in Washington DC.